DR
Therapeutic Areas
Strykagen Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Myomatrix Stabilization Program | Duchenne Muscular Dystrophy (DMD) | Preclinical |
| Diagnostics & Biomarkers | Muscular Dystrophy (Diagnosis/Prognosis) | Development |
| Drug | Indication | Phase |
|---|---|---|
| Myomatrix Stabilization Program | Duchenne Muscular Dystrophy (DMD) | Preclinical |
| Diagnostics & Biomarkers | Muscular Dystrophy (Diagnosis/Prognosis) | Development |